Canadian guideline on genetic screening for hereditary renal cell cancers

M. Neil Reaume, Gail E. Graham, Eva Tomiak, Suzanne Kamel-Reid, Michael A.S. Jewett, Georg A. Bjarnason, Normand Blais, Melanie Care, Darryl Drachenberg, Craig Gedye, Ronald Grant, Daniel Y.C. Heng, Anil Kapoor, Christian Kollmannsberger, Jean Baptiste Lattouf, Eamonn R. Maher, Arnim Pause, Dean Ruether, Denis Soulieres, Simon TanguaySandra Turcotte, Philippe D. Violette, Lori Wood, Joan Basiuk, Stephen E. Pautler

Research output: Contribution to journalArticlepeer-review

Abstract

Background: Hereditary renal cell cancer (RCC) is an ideal model for germline genetic testing. We propose a guideline of hereditary RCC specific criteria to suggest referral for genetic assessment. Methods: A review of the literature and stakeholder resources for existing guidelines or consensus statements was performed. Referral criteria were developed by expert consensus. Results: The criteria included characteristics for patients with RCC (age ≤45 years, bilateral or multifocal tumours, associated medical conditions and non-clear cell histologies with unusual features) and for patients with or without RCC, but a family history of specific clinical or genetic diagnoses. Conclusions: This guideline represents a practical RCC-specific reference to allow healthcare providers to identify patients who may have a hereditary RCC syndrome, without extensive knowledge of each syndrome. RCC survivors and their families can also use the document to guide their discussions with healthcare providers about their need for referral. The criteria refer to the most common hereditary renal tumour syndromes and do not represent a comprehensive or exclusive list. Prospective validation of the criteria is warranted.

Original languageEnglish
Pages (from-to)319-323
Number of pages5
JournalJournal of the Canadian Urological Association
Volume7
Issue number9-10 OCT
DOIs
Publication statusPublished - 9 Oct 2013

Fingerprint

Dive into the research topics of 'Canadian guideline on genetic screening for hereditary renal cell cancers'. Together they form a unique fingerprint.

Cite this